Cargando…

Immune response to pneumococcal polysaccharides 4 and 14 in elderly and young adults. I Antibody concentrations, avidity and functional activity

Streptococcus pneumoniae is a serious worldwide pathogen and the focus of numerous vaccine development projects. Currently the most widely accepted surrogate marker for evaluating the efficacy of a given vaccine is to utilize ELISA. Measurement of antibody concentration by ELISA without reduction in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kolibab, Kris, Smithson, S Louise, Shriner, Anne K, Khuder, Sadik, Romero-Steiner, Sandra, Carlone, George M, Westerink, MA Julie
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2005
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1184095/ https://www.ncbi.nlm.nih.gov/pubmed/15982420 http://dx.doi.org/10.1186/1742-4933-2-10

Ejemplares similares

Response to Pneumococcal Polysaccharide Vaccination in Newly Diagnosed HIV-Positive Individuals
por: Leggat, David J, et al.
Publicado: (2015)

Response to Pneumococcal Polysaccharide Vaccination in HIV-Positive Individuals on Long Term Highly Active Antiretroviral Therapy
por: Iyer, Anita S, et al.
Publicado: (2015)

Inflammatory Markers and Immune Response to Pneumococcal Vaccination in HIV-Positive and -Negative Adults
por: Iyer, Anita S., et al.
Publicado: (2016)

The Use of Professionalism Scenarios in the Medical School Interview Process: Faculty and Interviewee Perceptions
por: Kleshinski, James, et al.
Publicado: (2008)

Triptych of the Hermit Saints: pneumococcal polysaccharide vaccines for the elderly
por: Rijkers, Ger T, et al.
Publicado: (2018)

Effectiveness of 23-valent pneumococcal polysaccharide vaccine on diabetic elderly
por: Kuo, Chia-Sheng, et al.
Publicado: (2016)

Immunogenicity and safety of the 13-valent pneumococcal conjugate vaccine compared to the 23-valent pneumococcal polysaccharide vaccine in elderly Japanese adults
por: Shiramoto, Masanari, et al.
Publicado: (2015)

Effectiveness of the 23-Valent Pneumococcal Polysaccharide Vaccine (PPV23) against Pneumococcal Disease in the Elderly: Systematic Review and Meta-Analysis
por: Falkenhorst, Gerhard, et al.
Publicado: (2017)

Pneumococcal vaccination in persons living with HIV: Pneumococcal conjugate, polysaccharide or both?
por: Dhingra, Bhavna, et al.
Publicado: (2020)

Antibody recognition of the type 14 pneumococcal capsule. Evidence for a conformational epitope in a neutral polysaccharide
Publicado: (1989)

The effect of age on the response to the pneumococcal polysaccharide vaccine
por: Lee, Hyunju, et al.
Publicado: (2010)

Pneumococcal vaccination of older adults: Conjugate or polysaccharide?
por: Hollingsworth, Rosalind, et al.
Publicado: (2014)

Pneumococcal Polysaccharide Vaccine Ameliorates Murine Lupus
por: Cantarelli, Chiara, et al.
Publicado: (2019)

Effectiveness, immunogenicity and safety of 23-valent pneumococcal polysaccharide vaccine revaccinations in the elderly: a systematic review
por: Remschmidt, Cornelius, et al.
Publicado: (2016)

Comparison of immunogenicity and safety of an influenza vaccine administered concomitantly with a 13-valent pneumococcal conjugate vaccine or 23-valent polysaccharide pneumococcal vaccine in the elderly
por: Seo, Yu Bin, et al.
Publicado: (2017)

Vaccine effectiveness of the pneumococcal polysaccharide and conjugated vaccines in elderly and high-risk populations in preventing invasive pneumococcal disease: a systematic search and meta-analysis
por: Sikjær, Melina Gade, et al.
Publicado: (2023)

A Review of the Impact of Pneumococcal Polysaccharide Conjugate Vaccine (7-valent) on Pneumococcal Meningitis
por: Tin Tin Htar , Myint, et al.
Publicado: (2013)

Pneumococcal Conjugate Vaccination Followed by Pneumococcal Polysaccharide Vaccination in Lung Transplant Candidates and Recipients
por: Hoffman, Thijs W., et al.
Publicado: (2020)

Differences in Homing Potentials of Streptococcus pneumoniae–Specific Plasmablasts in Pneumococcal Pneumonia and After Pneumococcal Polysaccharide and Pneumococcal Conjugate Vaccinations
por: Palkola, Nina V., et al.
Publicado: (2015)

STUDIES ON THE INDUCTION OF IMMUNOLOGICAL UNRESPONSIVENESS TO PNEUMOCOCCAL POLYSACCHARIDE IN MICE
por: Siskind, Gregory W., et al.
Publicado: (1966)

PREVENTION OF PNEUMOCOCCAL PNEUMONIA BY IMMUNIZATION WITH SPECIFIC CAPSULAR POLYSACCHARIDES
por: MacLeod, Colin M., et al.
Publicado: (1945)

Pneumococcal Capsular Polysaccharide Structure Predicts Serotype Prevalence
por: Weinberger, Daniel M., et al.
Publicado: (2009)

Polysaccharide Responsiveness Is Not Biased by Prior Pneumococcal-Conjugate Vaccination
por: Bernth-Jensen, Jens Magnus, et al.
Publicado: (2013)

Pneumococcal Polysaccharide Vaccination in Pediatric Inflammatory Bowel Disease
por: Temtem, Tsega, et al.
Publicado: (2019)

Effects of Capsular Polysaccharide amount on Pneumococcal-Host interactions
por: Zhu, Jiaqi, et al.
Publicado: (2023)

Avid Editing
por: Kauffmann, Sam, et al.
Publicado: (2017)

An Avid Imitator
por: Farmakiotis, Dimitrios, et al.
Publicado: (2016)

Editing with Avid Media Composer 5: the official Avid guide.
por: Kennedy, Ashley
Publicado: (2010)

Economic Evaluation of Immunisation Programme of 23-Valent Pneumococcal Polysaccharide Vaccine and the Inclusion of 13-Valent Pneumococcal Conjugate Vaccine in the List for Single-Dose Subsidy to the Elderly in Japan
por: Hoshi, Shu-ling, et al.
Publicado: (2015)

Effectiveness of a 23-valent pneumococcal polysaccharide vaccine for the prevention of pneumococcal pneumonia in the elderly with chronic respiratory diseases: a case–control study of a single center
por: Masuda, Toshihiro, et al.
Publicado: (2021)

POLYSACCHARIDE IN DELAYED HYPERSENSITIVITY : I. PNEUMOCOCCAL POLYSACCHARIDE AS INDUCER AND ELICITOR OF DELAYED REACTIVITY IN GUINEA PIGS
por: Gerety, Robert J., et al.
Publicado: (1970)

Effectiveness of 23-valent pneumococcal polysaccharide vaccination in preventing community-acquired pneumonia hospitalization and severe outcomes in the elderly in Spain
por: Domínguez, Àngela, et al.
Publicado: (2017)

THE ANAMNESTIC ANTIBODY RESPONSE TO TYPE III SPECIFIC PNEUMOCOCCAL POLYSACCHARIDE
por: Paul, William E., et al.
Publicado: (1969)

CROSS-REACTIONS OF PNEUMOCOCCAL TYPES : QUANTITATIVE STUDIES WITH THE CAPSULAR POLYSACCHARIDES
por: Heidelberger, Michael, et al.
Publicado: (1964)

SYNTHESIS OF TYPE III PNEUMOCOCCAL POLYSACCHARIDE BY SUSPENSIONS OF RESTING CELLS
por: Bernheimer, Alan W.
Publicado: (1953)

Are the pneumococcal polysaccharide vaccines effective? Meta-analysis of the prospective trials
por: Moore, R Andrew, et al.
Publicado: (2000)

Pneumococcal polysaccharide vaccination in rheumatoid arthritis patients receiving tacrolimus
por: Migita, Kiyoshi, et al.
Publicado: (2015)

The Avid handbook: advanced techniques, strategies, and survival information for Avid editing systems
por: Staten, Greg, et al.
Publicado: (2009)

Effectiveness of the 23-valent polysaccharide pneumococcal vaccine against invasive pneumococcal disease in people 60 years or older
por: Vila-Corcoles, Angel, et al.
Publicado: (2010)

In-Hospital Pneumococcal Polysaccharide Vaccination Is Associated With Detection of Pneumococcal Vaccine Serotypes in Adults Hospitalized for Community-Acquired Pneumonia
por: Grijalva, Carlos G., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_mrd4pp3m1ru3400ktttb8398f2